View all news

PAP-linked Survival Rate, New COPD Prevalence, Benefits of Telemonitoring Ventilation Patients among 14 ResMed-supported Abstracts at ERS 2021

09/02/2021

What’s happening

ResMed, a global leader in sleep and respiratory care research and digitally 
connected solutions, is presenting 14 abstracts at the European Respiratory Society (ERS) International Congress 2021. Three of note listed below:

When: September 6-8, 2021

Study #1: The health and cost benefits of telemonitoring patients on home mechanical ventilation

  • Time: Monday 6 September, 13:15-14:15 CET (8:15-9:15 a.m. in Brazil)
  • Presenter: Claudia Albertini, ResMed, Head of Clinical Marketing, LATAM
  • Find the abstract: “Clinical and economic benefits of HMV telemonitoring in Brazil” (Session 249)
  • Contact: alessandra.parise@engajecomunicacao.com; 
    graziele.marronato@engajecomunicacao.com

Study #2: How many Europeans have chronic obstructive pulmonary disease (COPD) in 2020 – and may in 2050

  • Time: Tuesday 7 September, 09:30-11:00 CET
  • Presenter: Adam Benjafield, ResMed, vice president of Medical Affairs
  • Find the abstract: “An estimate of the European prevalence of COPD in 2050” (Session 328)
  • Contact: Jayme Rubenstein, +1 858.836.6798, news@resmed.com

Study #3: (late-breaking abstract): Do people with sleep apnea live longer when adherent on PAP?

  • Time: Wednesday 8 September, 11:15-12:45 CET
  • Presenter: Jean-Louis Pepin, Grenoble Alpes University, Grenoble, France
  • Find the abstract: “CPAP termination and all-cause mortality: a French nationwide database 
    analysis” (Session 494)
  • Contact: Jayme Rubenstein, +1 858.836.6798, news@resmed.com

For additional information about ResMed and its ERS abstracts, please email news@resmed.com. 

# # #

Multimedia Files:

View all news